Tarpada Sandip P, Morris Matthew T, Lian Jayson, Rashidi Sina
Albert Einstein College of Medicine, Bronx, NY, United States.
J Orthop. 2018 Feb 2;15(1):107-110. doi: 10.1016/j.jor.2018.01.040. eCollection 2018 Mar.
Despite advances elucidating the causes of lateral and medial epicondylitis, the standard of care remains conservative management with NSAIDs, physical therapy, bracing, and rest. Scar tissue formation provoked by conservative management creates a tendon lacking the biomechanical properties and mechanical strength of normal tendon. The following review analyzes novel therapies to regenerate tendon and regain function in patients with epicondylitis. These treatments include PRP injection, BMAC, collagen-producing cell injection, and stem cell treatments. While these treatments are in early stages of investigation, they may warrant further consideration based on prospects of pain alleviation, function enhancement, and improved healing.
尽管在阐明外侧和内侧上髁炎病因方面取得了进展，但护理标准仍然是使用非甾体抗炎药、物理治疗、支具和休息进行保守治疗。保守治疗引发的瘢痕组织形成会导致肌腱缺乏正常肌腱的生物力学特性和机械强度。以下综述分析了用于上髁炎患者肌腱再生和恢复功能的新疗法。这些治疗方法包括富血小板血浆注射、骨髓抽吸浓缩物、产胶原细胞注射和干细胞治疗。虽然这些治疗尚处于研究初期，但基于缓解疼痛、增强功能和改善愈合的前景，它们可能值得进一步考虑。
